The document describes the Canadian Syncope Risk Score, which predicts the risk of serious adverse events within 30 days for patients aged 16 or older presenting with syncope within 24 hours. It should not be used for patients with prolonged loss of consciousness, altered mental status, seizures, major trauma, intoxication, language barriers, or head trauma causing loss of consciousness. The score has been externally validated based on data presented at the 2018 Society for Academic Emergency Medicine Annual Meeting. It identifies patients at higher risk of outcomes like death, arrhythmia, or non-cardiac causes who may need further investigation or admission.
The document describes the Canadian Syncope Risk Score, which predicts the risk of serious adverse events within 30 days for patients aged 16 or older presenting with syncope within 24 hours. It should not be used for patients with prolonged loss of consciousness, altered mental status, seizures, major trauma, intoxication, language barriers, or head trauma causing loss of consciousness. The score has been externally validated based on data presented at the 2018 Society for Academic Emergency Medicine Annual Meeting. It identifies patients at higher risk of outcomes like death, arrhythmia, or non-cardiac causes who may need further investigation or admission.
The document describes the Canadian Syncope Risk Score, which predicts the risk of serious adverse events within 30 days for patients aged 16 or older presenting with syncope within 24 hours. It should not be used for patients with prolonged loss of consciousness, altered mental status, seizures, major trauma, intoxication, language barriers, or head trauma causing loss of consciousness. The score has been externally validated based on data presented at the 2018 Society for Academic Emergency Medicine Annual Meeting. It identifies patients at higher risk of outcomes like death, arrhythmia, or non-cardiac causes who may need further investigation or admission.
Predicts 30-day serious adverse events in patients presenting with syncope.
INSTRUCTIONS Applicable to patients ≥16 years old presenting ≤24 hours of syncope. Do not use if: prolonged (>5 min) LOC, change in mental status from baseline, obvious witnessed seizure, major trauma, intoxication, language barrier, or head trauma causing LOC. This calculator is externally validated, according to data presented at the Society for Academic Emergency Medicine Annual Meeting 2018. When to Use
Patients ≥16 years old presenting ≤24 hours of syncope.
Do not use in patients with any of the following: o Prolonged (>5 min) LOC. o Change in mental status from baseline. o Obvious witnessed seizure. o Major trauma requiring hospital admission. o Intoxication with alcohol or illicit drugs. o Language barrier. o Head trauma causing LOC.
Pearls/ Pitfalls
Predicts risk of 30-day serious adverse events associated with syncope,
defined as any of the following: death, arrhythmia, non-arrhythmic cardiac causes, or non-cardiac causes (see Evidence for full list). In 2020, the CSRS was successfully validated (see Evidence, below).
Why Use
Syncope is a common, often benign presenting complaint in emergency
departments, that sometimes has life-threatening underlying causes. The Canadian Syncope Risk Score identifies patients with syncope who are at higher risk of adverse outcomes. Can potentially avoid unnecessary investigation and/or admission.
ABOUT THE CREATOR
Venkatesh Thiruganasambandamoorthy, MBBS, CCFP-EM, MSc, is an emergency physician and associate professor in the department of emergency medicine and epidemiology / community medicine at the Ottawa Hospital Research Institute in Ottawa, Canada. He heads the Venk Group, a research program that aims to reduce morbidity and mortality from syncope and pre-syncope using robust risk-stratification, particularly for identifying low-risk patients. Dr. Thiruganasambandamoorthy is a founding member of the Canadian Syncope Alliance, a national collaboration aiming to improve syncope care in Canada. Tabel Analisa Masing-Masing Skoring Luaran Penelitian Populasi Variabel Prediktor Validasi Pengukruan Boston Populasi Tanda penurunan Intervensi Internal: Syncope asal: A volume. kritikal atau Sensitivitas Rule, 2007 priori Tanda vital abnormal kejadian yang (Se) 97%; (Risiko di IGD. tidak Spesifisitas jangka Validasi: Tanda dan gejala diinginkan (Sp) 62% Pendek) 362 sindrom koroner akut. (KTD) dalam pasien Tanda dan gejala 30 hari. Eksternal: - gangguan konduksi. Riwayat penyakit jantung. Riwayat kematian mendadak pada keluarga. Kejadian gangguan sistem saraf pusat pertama kali. Penyakit katup jantung.
Canadian Populasi Predisposisi sinkop Komplikasi Internal:
Syncope asal: vasovagal serius dalam 30 Sensitivitas Rule, 2016 4.030 (prodromal/pemicu). hari: Kematian, (Se) 97,8%; (Risiko pasien Riwayat penyakit aritmia, infark Spesifisitas jangka jantung. miokard, (Sp) 44,3% Pendek) Validasi: Tekanan darah sistolik emboli paru, 3.819 <90 atau >180 mmHg. diseksi aorta, Eksternal: pasien Peningkatan troponin. stroke, atau Sensitivitas Aksis QRS abnormal. intervensi lebih rendah Durasi gelombang prosedural QRS. untuk sinkop. Interval QT. Diagnosis IGD mengarah ke sinkop vasovagal/kardiak
EGSYS Populasi Riwayat Palpitasi. Probabilitas Internal:
Score, asal: 260 EKG abnormal atau sinkop Sensitivitas 2008 pasien riwayat penyakit kardiogenk (Se) 92%; (Risiko jantung. dalam 2 tahun. Spesifisitas jangka Validasi: Sinkop saat bergiat (Sp) 69% Pendek 258 atau posisi supinasi. dan jangka pasien Prodromal gejala Eksternal: Panjang) otonom. Se 56% ; Sp Faktor 84% presipitasi/predisposisi. OESIL Populasi Temuan EKG Mortalitas 1 Internal: Risk Score, asal: 270 abnormal. tahun Sensitivitas 2003 pasien Tidak adanya gejala (Se) 100%; (risiko prodromal. Spesifisitas jangka Validasi: Usia >65 tahun. (Sp) 22% Panjang) 328 Riwayat penyakit pasien jantung. Eksternal: Se 95% ; Sp 31% ROSE Populasi Anemia (Hb ≤9 g/dl) Komplikasi Internal: study, asal: 550 Bradikardi (<50 dalam 1 bulan: Sensitivitas 2010 pasien x/menit). Kematian, (Se) 87%; (risiko Pengukuran Brain aritmia, infark Spesifisitas jangka Validasi: Natriuretic Peptide. miokard, (Sp) 66% pendek) 550 Nyeri dada dengan emboli paru, Hasil luaran pasien sinkop. stroke, dalam 1 EKG menunjukkan perdarahan tahun: Se gelombang Q subaraknoid, 72%; Sp patologis. transfusi darah 71% Saturasi oksigen. atau intervensi Pemeriksaan rektal prosedural akut, Eksternal: - untuk adanya pemasangan perdarahan. pacu jantung. San Populasi Abnrmalitas EKG. Komplikasi Internal: Francisco asal: 684 Gagal jantung. serius dalam 7 Sensitivitas Syncope pasien Hematkrit <30. hari: (Se) 98%; Rule, 2004 Sesak nafas. sindromkoroner Spesifisitas (risiko Validasi: Tekanan darah sistolik akut, emboli (Sp) 56% jangka 791 <90 mmHg paru, stroke, pendek) pasien aritmia, Eksternal: perdarahan Se 87% ; Sp subarknoid, 52% kunjungan IGD berulang, re- admisi.